Bioinquire

ProteoIQ 2.0 provides researchers with a unified software solution for the major proteomic quantification strategies and adds tools for distilling biological meaning from high-throughput proteomic data in a manner that was not previously possible.

BioInquire, LLC is awarded a Phase II Small Business Technology Transfer (STTR) grant totaling $747K. The grant, entitled Development of Software for Comparative and Quantitative Clinical Proteomics, was awarded by the National Institute of Health.

BioInquire releases a new version of the innovative software ProteoIQ with enhanced functionality for analyzing data from proteome wide studies. New enhancements make it easier to identify modified proteins.